22157.jpg
Global Light Activated Therapies Market 2021-2030: Over 635 Patents have been Filed/Granted in Past 3 Years
November 26, 2021 05:28 ET | Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Global Light Activated Therapies Market: Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts,...
2019 logo_150x35_jpg.jpg
Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 10, 2021 05:55 ET | Novan, Inc.
– Company executing on plans for three potential New Drug Application (NDA) filings in three years with the first submission targeted in Q3 2022 for lead program SB206 in molluscum contagiosum – –...
vmr logo registered_ blue.png
Photodynamic Therapy Market size worth $ 2,308.17 Million, Globally, by 2028 at 8.74% CAGR: Verified Market Research®
November 04, 2021 11:15 ET | Verified Market Research
Jersey City, New Jersey, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Photodynamic Therapy Market” By Product (Photosensitizer Drug and Photodynamic...
22157.jpg
Global $7.4 Billion Dermatology CRO Market by Type, Service, Region, Segment and Forecasts 2021-2028 Includes Size, Share & Trends Analysis
October 25, 2021 07:08 ET | Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical, Drug Discovery), By Service (Clinical Monitoring,...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
September 16, 2021 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
2019 logo_150x35_jpg.jpg
Novan Announces Strategic Priorities and Outlines Key Milestones
September 09, 2021 07:00 ET | Novan, Inc.
– Company planning for three potential New Drug Application (NDA) filings in three years with the first submission expected in Q3 2022 for lead program SB206 in molluscum contagiosum – – Late-stage...
22157.jpg
Worldwide Anti-acne Cosmetics Industry to 2025 - Key Drivers, Challenges and Trends
April 14, 2021 07:18 ET | Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Global Anti-acne Cosmetics Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has been monitoring the...
22157.jpg
World Acne Market Spotlight Report 2021: GlaxoSmithKline has the Highest Number of Completed Clinical Trials for Acne with 35 Trials
April 12, 2021 06:53 ET | Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Acne" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Acne market, comprising...
Skinopathy dark logo (1).png
GetSkinHelp.com launches service that reduces wait times to see a dermatologist from several months to mere hours
March 11, 2021 10:30 ET | Skinopathy
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- Skinopathy Inc., a Canadian medical technology company, is expanding and introducing a new service through its flagship platform, GetSkinHelp.com, that...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Psoriasis
October 06, 2020 09:30 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...